Search results
Results From The WOW.Com Content Network
v. t. e. Gender-affirming surgery for male-to-female transgender women or transfeminine non-binary people describes a variety of surgical procedures that alter the body to provide physical traits more comfortable and affirming to an individual's gender identity and overall functioning. Often used to refer to vaginoplasty, sex reassignment ...
Gender-affirming surgery for female-to-male transgender people includes a variety of surgical procedures that alter anatomical traits to provide physical traits more comfortable to the trans man's male identity and functioning. Often used to refer to phalloplasty, metoidoplasty, or vaginectomy, sex reassignment surgery can also more broadly ...
Gender-affirming surgery is a surgical procedure, or series of procedures, that alters a person's physical appearance and sexual characteristics to resemble those associated with their identified gender. The phrase is most often associated with transgender health care and intersex medical interventions, although many such treatments are also ...
Summary. Medicare pays for medically necessary gender affirmation for transgender people who meet certain criteria, such as having a gender dysphoria diagnosis. Medicare Part A covers inpatient ...
Bowers operates at Mills-Peninsula Medical Center in Burlingame, California, and San Mateo Surgery Center in San Mateo, California. From 2003 to 2010, she practiced in the town of Trinidad, Colorado, where she apprenticed under Stanley Biber, a pioneer in sex reassignment surgery, before going solo in July 2003. [1] [5] [6] [7]
Metoidioplasty, metaoidioplasty, or metaidoioplasty[ 2] (informally called a meto or meta) is a female-to-male gender-affirming surgery. [ 3] Testosterone replacement therapy gradually enlarges the clitoris to a mean maximum size of 4.6 cm (1.8 in) [ 4] (as the clitoris and the penis are developmentally homologous ).
v. t. e. The Standards of Care for the Health of Transgender and Gender Diverse People ( SOC) is an international clinical protocol by the World Professional Association for Transgender Health (WPATH) outlining the recommended assessment and treatment for transgender and gender-diverse individuals across the lifespan including social, hormonal ...
A 2019 systematic review and meta-analysis found an incidence rate of VTE of 2.3 per 1000 person-years with feminizing hormone therapy in transgender women. [329] For comparison, the rate in the general population has been found to be 1.0–1.8 per 1000 person-years, and the rate in premenopausal women taking birth control pills has been found ...